【24h】

Impact of Dialysate Sodium Concentration Lowering on Home Blood Pressure Variability in Hemodialysis Patients

机译:透析液钠浓度降低血液透析患者家庭血压变异性的影响

获取原文
获取原文并翻译 | 示例
           

摘要

Abstract Blood pressure variability is an independent risk factor for mortality and cardiovascular events in hemodialysis patients. Dialysate sodium concentration may not only have effects on blood pressure but also on blood pressure variability. We investigated whether dialysate sodium concentration lowering could decrease home blood pressure variability in hemodialysis patients. Forty‐three hemodialysis patients at their dry weight assessed by bioimpedance methods with pre‐dialysis serum sodium 136?mmol/L were recruited. Firstly, patients underwent a 1‐month standard dialysis with dialysate sodium concentration of 138?mmol/L, and then the dialysate sodium concentration was decreased to 136?mmol/L for 8?weeks. Home blood pressure was assessed on waking up and at bedtime for 1 week. Coefficient of variation was used to define home blood pressure variability. After the intervention, whole‐day systolic blood pressure variability decreased from 5.7?±?2.6% to 4.3?±?1.7% and evening systolic blood pressure variability decreased from 7.9?±?4.1% to 6.2?±?3.1%. Morning systolic blood pressure variability had a reduction from 7.8?±?2.4% to 5.9?±?3.3% but did not achieve statistical significance ( P ?=?0.077). Whole‐day, morning and evening systolic blood pressure were decreased significantly. Less changes were observed in diastolic blood pressure parameters. Interdialytic weight gain mildly but significantly decreased. Volume parameters, dietary sodium intake and incidence of adverse events were similar throughout the study period. Lowering dialysate sodium concentration could improve home blood pressure variability among hemodialysis patients who had achieved their dry weight.
机译:摘要血压变异性是血液透析患者死亡率和心血管事件的独立危险因素。透析液钠浓度可能不仅可以对血压产生影响,也可能对血压变异性产生影响。我们调查了透析液钠浓度降低是否可降低血液透析患者的家庭血压变异性。由生物阻抗方法进行四十三血液透析患者,通过预透析血清钠& 136〜Mmol / L。首先,患者经历了1个月的标准透析,透析液钠浓度为138Ω·莫醇/ L,然后将透析液钠浓度降低至136Ω·莫尔/升8?周。在醒来和睡前评估家庭血压1周。使用系数用于定义家庭血压变异性。干预后,全天收缩压变化从5.7α±2.6%降低到4.3?±1.7%和晚上收缩压变化从7.9?±4.1%到6.2?±3.1%。早晨收缩压变异性从7.8α±±2.4%到5.9?±3.3%,但未达到统计学意义(P?= 0.077)。全天候,早晚的收缩压血压显着下降。在舒张压参数中观察到更少的变化。赤阳体重增长温和但显着降低。在整个研究期间,体积参数,膳食钠摄入和不良事件的发生率相似。降低透析液钠浓度可以改善血液透析患者的家庭血压变异性,血液透析患者达到干重。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号